Citation Impact
Citing Papers
SuFEx-enabled, agnostic discovery of covalent inhibitors of human neutrophil elastase
2019 StandoutNobel
Deep-Sea Archaea Fix and Share Nitrogen in Methane-Consuming Microbial Consortia
2009 Science
Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa
2010 Standout
Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve
2011 Standout
Induction of Colonic Regulatory T Cells by Indigenous Clostridium Species
2010 StandoutScience
Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients
2008 Standout
Wild-Type KRAS Is Required for Panitumumab Efficacy in Patients With Metastatic Colorectal Cancer
2008 Standout
A taxonomic note on the genus Lactobacillus: Description of 23 novel genera, emended description of the genus Lactobacillus Beijerinck 1901, and union of Lactobacillaceae and Leuconostocaceae
2020 Standout
Diversity oriented clicking delivers β-substituted alkenyl sulfonyl fluorides as covalent human neutrophil elastase inhibitors
2022 StandoutNobel
Nanoparticle Delivery of miR-708 Mimetic Impairs Breast Cancer Metastasis
2019
Engineering precision nanoparticles for drug delivery
2020 Standout
EGFR Antagonists in Cancer Treatment
2008 Standout
Sirolimus Therapy of Focal Segmental Glomerulosclerosis Is Associated With Nephrotoxicity
2007
Imaging beyond the proteome
2012 StandoutNobel
Barrier-protective function of intestinal epithelial Toll-like receptor 2
2008
The microbiota in adaptive immune homeostasis and disease
2016 StandoutNature
NLRP6 Inflammasome Regulates Colonic Microbial Ecology and Risk for Colitis
2011 Standout
Comparing antibody and small-molecule therapies for cancer
2006
Lactobacillus reuteri –induced Regulatory T cells Protect against an Allergic Airway Response in Mice
2008
Chronic inflammation in the etiology of disease across the life span
2019 Standout
Human Genetics Shape the Gut Microbiome
2014 Standout
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy
2019 Standout
Probiotics and gastrointestinal disease: successes, problems and future prospects
2009
Epidermal growth factor receptor mutations in lung cancer
2007 Standout
Lung Cancer
2008 Standout
Epidermal Growth Factor Receptor Targeting in Cancer
2006
The resurgence of platinum-based cancer chemotherapy
2007 Standout
The Human Intestinal Microbiome in Health and Disease
2016 Standout
Cross-Talk between Probiotic Bacteria and the Host Immune System1,
2007
Crohn's disease
2012 Standout
Type I interferons in infectious disease
2015 Standout
Natural Substrates of Dipeptidyl Peptidase IV
2002
Molecular Targets for Green Tea in Prostate Cancer Prevention
2003
Monoclonal antibodies against the iron regulated outer membrane Proteins of Acinetobacter baumannii are bactericidal
2001
Biomarkers for Clinical Benefit of Immune Checkpoint Inhibitor Treatment—A Review From the Melanoma Perspective and Beyond
2018
Role of the Microbiota in Immunity and Inflammation
2014 Standout
Metagenomic biomarker discovery and explanation
2011 Standout
Host Remodeling of the Gut Microbiome and Metabolic Changes during Pregnancy
2012 Standout
Role of the gut microbiota in immunity and inflammatory disease
2013 Standout
Targeting cancer with small molecule kinase inhibitors
2008 Standout
Oral Treatment with Live Lactobacillus reuteri Inhibits the Allergic Airway Response in Mice
2007
Bone vascular niche E-selectin induces mesenchymal–epithelial transition and Wnt activation in cancer cells to promote bone metastasis
2019
Cellular processing of platinum anticancer drugs
2005 Standout
Crohn's disease
2016 Standout
Cetuximab in advanced non-small cell lung cancer
2006
The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes
2006 Standout
Intestinal mucosal barrier function in health and disease
2009 Standout
CRISPR–Cas9-assisted recombineering in Lactobacillus reuteri
2014
The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans
2021 StandoutNobel
The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic
2014 Standout
How nutrition and the maternal microbiota shape the neonatal immune system
2017
Anaerobic oxidation of methane coupled to nitrate reduction in a novel archaeal lineage
2013 StandoutNature
Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy
2017 Standout
Applications of CRISPR technologies in research and beyond
2016 StandoutNobel
Genetics and pathogenesis of inflammatory bowel disease
2011 StandoutNature
Regulation of type I interferon responses
2013 Standout
Tumor metastasis: mechanistic insights and clinical challenges
2006 Standout
Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms
2013 Standout
Emerging drugs for non-small-cell lung cancer
2007
Combination raltitrexed (Tomudex®)–oxaliplatin: a step forward in the struggle against mesothelioma? The Institut Gustave Roussy experience with chemotherapy and chemo-immunotherapy in mesothelioma
2000
Double-Stranded RNA of Intestinal Commensal but Not Pathogenic Bacteria Triggers Production of Protective Interferon-β
2013
Gefitinib (ZD1839, Iressa®) in non‐small‐cell lung cancer: a review of clinical trials from a daily practice perspective
2005
The pros, cons, and many unknowns of probiotics
2019 Standout
Capecitabine in malignant mesothelioma: a phase II trial by the Cancer and Leukemia Group B (39807)
2003
The microbial nitrogen-cycling network
2018 Standout
Gut microbiota in human metabolic health and disease
2020 Standout
The gut microbiota shapes intestinal immune responses during health and disease
2009 Standout
Acinetobacter baumannii : Emergence of a Successful Pathogen
2008 Standout
Differential immunomodulatory properties of Bifidobacterium logum strains: relevance to probiotic selection and clinical applications
2007
Gut Microbiota in Health and Disease
2010 Standout
Nitrate reduction and the nitrogen cycle in archaea
2004
Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Alone in Patients With Malignant Pleural Mesothelioma
2003 Standout
Epidermal Growth Factor Receptor Inhibitors in the Treatment of Non–Small-Cell Lung Cancer
2005
Pomegranate fruit juice for chemoprevention and chemotherapy of prostate cancer
2005 Standout
Food-Grade Bacteria Expressing Elafin Protect Against Inflammation and Restore Colon Homeostasis
2012
Cellular and molecular pharmacology of oxaliplatin.
2002
Secretion of Insulinotropic Proteins by Commensal Bacteria: Rewiring the Gut To Treat Diabetes
2008
Oral Delivery of Biologics for Precision Medicine
2019
cis -Diammine(pyridine)chloroplatinum(II), a monofunctional platinum(II) antitumor agent: Uptake, structure, function, and prospects
2008 StandoutNobel
Fibrosis — A Common Pathway to Organ Injury and Failure
2015 Standout
Engineered Commensal Bacteria Reprogram Intestinal Cells Into Glucose-Responsive Insulin-Secreting Cells for the Treatment of Diabetes
2015
Increased EGFR Gene Copy Number Detected by Fluorescent In Situ Hybridization Predicts Outcome in Non–Small-Cell Lung Cancer Patients Treated With Cetuximab and Chemotherapy
2008
Works of Catherine Daniel being referenced
Monoclonal Antibodies to Human Pancreatic Procolipase: Production and Characterization by Competitive Binding Studies
1994
Matrix Metalloproteinase Inhibitors Cause Cell Cycle Arrest and Apoptosis in Glomerular Mesangial Cells
2001
Neonatal colonization of mice with Lactobacillus plantarum producing the aeroallergen Bet v 1 biases towards Th1 and T-regulatory responses upon systemic sensitization
2010
Drosophila Perpetuates Nutritional Mutualism by Promoting the Fitness of Its Intestinal Symbiont Lactobacillus plantarum
2017
A Flexible Reporter System for Direct Observation and Isolation of Cancer Stem Cells
2014
Proinflammatory Effects in Experimental Mesangial Proliferative Glomerulonephritis of the Immunosuppressive Agent SDZ RAD, a Rapamycin Derivative
2000
Characterization of theAcinetobacter baumanniiFur regulator: cloning and sequencing of thefurhomolog gene
1999
Gut microbiota limits heavy metals burden caused by chronic oral exposure
2013
Potential and Opportunities for Use of Recombinant Lactic Acid Bacteria in Human Health
2004
Modulation of allergic immune responses by mucosal application of recombinant lactic acid bacteria producing the major birch pollen allergen Bet v 1
2006
Circulating tumor DNA changes for early monitoring of anti-PD1 immunotherapy: a proof-of-concept study
2017
Prevention and Treatment of Colitis With Lactococcus lactis Secreting the Immunomodulatory Yersinia LcrV Protein
2007
Recombinant lactic acid bacteria as mucosal biotherapeutic agents
2011
Selecting Lactic Acid Bacteria for Their Safety and Functionality by Use of a Mouse Colitis Model
2006
Randomized phase II study of cetuximab in combination with cisplatin (C) and vinorelbine (V) vs. CV alone in the first-line treatment of patients (pts) with epidermal growth factor receptor (EGFR)-expressing advanced non-small-cell lung cancer (NSCLC)
2004
Raltitrexed (‘Tomudex’) and oxaliplatin: an active out-patient regimen in malignant mesothelioma
1999
Phase I, Dose-Finding, and Pharmacokinetic Study of Raltitrexed Combined With Oxaliplatin in Patients With Advanced Cancer
2000
Ammonia Switch-Off of Nitrogen Fixation in the Methanogenic Archaeon Methanococcus maripaludis : Mechanistic Features and Requirement for the Novel GlnB Homologues, NifI 1 and NifI 2
2001
Mucosal co-application of lactic acid bacteria and allergen induces counter-regulatory immune responses in a murine model of birch pollen allergy
2003
Randomized phase II study of cetuximab in combination with cisplatin (C) and vinorelbine (V) vs. CV alone in the first-line treatment of patients (pts) with epidermal growth factor receptor (EGFR)-expressing advanced non-small-cell lung cancer (NSCLC)
2004